Patents by Inventor Ali Areffard

Ali Areffard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccines against HPV
    Patent number: 9901635
    Abstract: The present invention relates to therapeutic compounds, such as vaccines against human papillomavirus (HPV) and in particular to DNA vaccines against HPV16 or HPV18. The invention further relates to protein construct encoding homodimeric peptides, which peptides may be released from a DNA vaccine or used separately. Further described are pharmaceutical formulations, host cells and methods for producing the vaccines, as well as methods for the treatment of various HPV induced diseases, such as cancers and infectious diseases by application.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: February 27, 2018
    Assignee: Vaccibody AS
    Inventors: Ole Henrik Brekke, Agnete Brunsvik Fredriksen, Ali Areffard, Mona Mari Lindeberg
  • VACCINES AGAINST HPV
    Publication number: 20150306217
    Abstract: The present invention relates to therapeutic compounds, such as vaccines against human papillomavirus (HPV) and in particular to DNA vaccines against HPV16 or HPV18. The invention further relates to protein construct encoding homodimeric peptides, which peptides may be released from a DNA vaccine or used separately. Further described are pharmaceutical formulations, host cells and methods for producing the vaccines, as well as methods for the treatment of various HPV induced diseases, such as cancers and infectious diseases by application.
    Type: Application
    Filed: December 20, 2012
    Publication date: October 29, 2015
    Inventors: Ole Henrik Brekke, Agnete Brunsvik Fredriksen, Ali Areffard, Mona Mari Lindeberg
  • VACCINES AGAINST HPV
    Publication number: 20150056197
    Abstract: The present invention relates to therapeutic compounds, such as vaccines against human papillomavirus (HPV) and in particular to DNA vaccines against HPV16 or HPV18. The invention further relates to protein construct encoding homodimeric peptides, which peptides may be released from a DNA vaccine or used separately. Further described are pharmaceutical formulations, host cells and methods for producing the vaccines, as well as methods for the treatment of various HPV induced diseases, such as cancers and infectious diseases by application.
    Type: Application
    Filed: December 20, 2012
    Publication date: February 26, 2015
    Inventors: Ole Henrik Brekke, Agnete Brunsvik Fredriksen, Ali Areffard, Mona Mari Lindeberg